MYD88 mutated and wild-type Waldenström’s Macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4

• Maria Luisa Guerrera,
• Nickolas Tsakmaklis,
• Lian Xu,
• Guang Yang,
• Maria Demos,
• Amanda Kofides,
• Gloria G. Chan,
• Robert J. Manning,
• Xia Liu,
• Jiaji G. Chen,
• Manit Munshi,
• Christopher J. Patterson,
• Jorge J. Castillo,
• Toni Dubeau,
• Joshua Gustine,
• Ruben D. Carrasco,
• Luca Arcaini,
• Marzia Varettoni,
• Mario Cazzola,
• Steven P. Treon,
• Zachary R. Hunter

Affiliations

Maria Luisa Guerrera

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA;Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA;Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Nickolas Tsakmaklis

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA

Lian Xu

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA

Guang Yang

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA;Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Maria Demos

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA

Amanda Kofides

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA

Gloria G. Chan

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA

Robert J. Manning

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA

Xia Liu

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA

Jiaji G. Chen

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA

Manit Munshi

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA

Christopher J. Patterson

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA

Jorge J. Castillo

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA;Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Toni Dubeau

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA

Joshua Gustine

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA

Ruben D. Carrasco

Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA;Department of Pathology, Brigham & Women’s Hospital, Boston, MA, USA

Luca Arcaini

Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;Department of Molecular Medicine, University of Pavia, Italy

Marzia Varettoni

Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Mario Cazzola

Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;Department of Molecular Medicine, University of Pavia, Italy

Steven P. Treon

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA;Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

Zachary R. Hunter

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA;Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA